Prosta Q Clinical Studies
Prosta-Q was tested in a controlled clinical study by the Institute of
Male Urology (IMU). This study was led by Dr. Daniel Shoskes, M.D. at
the UCLA Medical Center and showed that 82% of Males taking Prosta-Q attained
relief from the symptoms of Non-Bacterial Chronic Stage III Prostatitis.
These results were published in the American Medical Gold Journal of
Urology. The Prosta-Q solution is also cited as a primary method of treatment
for Chronic Non-bacterial Stage III Prostatitis in various authoritative
resources and books including "The Textbook on Prostatitis"
and "The Prostatitis Manual".
Early studies with bioflavonoids for prostatitis treatment were disappointing
because of their low and inconsistent absorption rates. Dr. Daniel Shoskes,
during his position as the Director of Prostate Research at the Institute
for Male Urology and Chief of Renal Transplantation at the Cleveland Clinic,
Florida, in association with his colleagues, recognized this, structured
a formula specifically designed to increase bioavailability.
The results of the IMU's research work in Chronic Prostatitis patients
using Prosta-Q were dramatic and compelling in significantly and rapidly
improving patients' symptoms.
Other beneficial effects of bioflavonoid intake include reduced risk
of heart disease and anti-cancer effects.
>>
best deal on Prosta Q - go to the store
|
